Valeant Pharmaceuticals International Inc (NYSE:VRX)

24.27
Delayed Data
As of Jun 22
 -0.45 / -1.82%
Today’s Change
10.94
Today|||52-Week Range
27.79
+16.79%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Paulson & Co Inc
Director
Sale3/06/20187,066,629$15.40$108.8M+58.42%
Paulson & Co Inc
Director
Buy3/06/20187,066,629$15.40$108.8M+58.42%
Paulson & Co Inc
Director
Buy11/16/2017344,216$14.40$5.0M+69.25%
Paulson & Co Inc
Director
Sale11/16/2017344,216$14.39$5.0M+69.25%
Papa Joseph C
Chairman & Chief Executive Officer
Buy3/13/201830,000$16.05$481.5K+50.93%
Humphries William D
Chairman
Sale1/03/201814,730$20.78$306.1K+5.48%
Herendeen Paul S
Chief Financial Officer & Executive Vice President
Sale8/23/201717,175$14.14$242.9K+68.31%
Herendeen Paul S
Chief Financial Officer & Executive Vice President
Buy3/13/201815,000$16.10$241.5K+50.93%
De Schutter Richard U
Director
Buy3/08/201810,000$15.34$153.4K+58.94%
De Schutter Richard U
Director
Buy11/17/201710,000$14.33$143.3K+65.21%
Page of 5